Why the study?
Does the subcutaneous implantable cardioverter-defibrillator (S-ICD) provide safe and effective therapy compared to transvenous ICDs in patients at risk for sudden cardiac death?
Population
Patients at risk for sudden cardiac death with an indication for an implantable cardioverter-defibrillator…
Comparison
Subcutaneous implantable cardioverter-defibrillat… vs Transvenous implantable cardioverter-defibrillator
Design
Review
Authors
Loading...
May reduce lead-related complications with S-ICD; leaves open need for randomized data on long-term efficacy.
Does the subcutaneous implantable cardioverter-defibrillator (S-ICD) provide safe and effective therapy compared to transvenous ICDs in patients at risk for sudden cardiac death?
The S-ICD is a safe and effective alternative to transvenous ICDs for the prevention of sudden cardiac death in patients who do not require pacing or CRT.
Kuschyk et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: